ZBHZIMMER BIOMET HOLDINGS, INC.

NYSE zimmerbiomet.com


$ 113.26 $ 0.14 (0.12 %)    

Tuesday, 04-Jun-2024 12:50:10 EDT
QQQ $ 454.82 $ 0.62 (0.14 %)
DIA $ 398.57 $ 1.37 (0.36 %)
SPY $ 530.36 $ 0.09 (0.02 %)
TLT $ 91.26 $ 0.37 (0.4 %)
GLD $ 225.37 $ -1.08 (-0.5 %)
$ 113.12
$ 112.82
$ 0.00 x 0
$ 0.00 x 0
$ 112.74 - $ 114.25
$ 101.61 - $ 146.61
1,662,962
na
23.33B
$ 1.10
$ 24.23
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-23-2024 12-31-2023 10-K
3 11-07-2023 09-30-2023 10-Q
4 08-01-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-02-2022 09-30-2022 10-Q
8 08-02-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-03-2021 06-30-2021 10-Q
13 05-04-2021 03-31-2021 10-Q
14 02-22-2021 12-31-2020 10-K
15 11-06-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-11-2020 03-31-2020 10-Q
18 02-21-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-05-2019 06-30-2019 10-Q
21 05-06-2019 03-31-2019 10-Q
22 02-26-2019 12-31-2018 10-K
23 11-01-2018 09-30-2018 10-Q
24 08-06-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-06-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 03-01-2017 12-31-2016 10-K
31 11-08-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 02-29-2016 12-31-2015 10-K
35 11-09-2015 09-30-2015 10-Q
36 08-10-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-23-2015 12-31-2014 10-K
39 11-05-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 barclays-maintains-underweight-on-zimmer-biomet-holdings-lowers-price-target-to-125

Barclays analyst Matt Miksic maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Underweight and lowers the price target from...

 goldman-sachs-initiates-coverage-on-zimmer-biomet-holdings-with-neutral-rating-announces-price-target-of-129

Goldman Sachs analyst David Roman initiates coverage on Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral rating and announce...

 needham-reiterates-hold-on-zimmer-biomet-holdings

Needham analyst Mike Matson reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Hold.

 zimmer-biomet-plans-returning-at-least-65-of-free-cash-flow-to-shareholders-through-dividends-and-share-buybacks-says-board-approved-new-stock-repurchase-of-up-to-2b-in-common-stock

At today's event, Zimmer Biomet provided its long-range plan for 2024 through 2027, including delivering: Mid-single-dig...

Core News & Articles

The partnership offers a comprehensive, turnkey solution to surgeons and institutions looking to expand their orthopedic ASC fo...

 orthopedic-implants-maker-zimmer-biomet-gains-analyst-upgrade-amid-promising-growth-from-new-products-demographic-trends

Zimmer Biomet receives an upgrade from Argus Research due to new product launches and strategic acquisitions.

 argus-research-upgrades-zimmer-biomet-holdings-to-buy-announces-150-price-target

Argus Research analyst David Toung upgrades Zimmer Biomet Holdings (NYSE:ZBH) from Hold to Buy and announces $150 price target.

 needham-reiterates-hold-on-zimmer-biomet-holdings

Needham analyst Mike Matson reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Hold.

 truist-securities-maintains-hold-on-zimmer-biomet-holdings-lowers-price-target-to-130

Truist Securities analyst Richard Newitter maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Hold and lowers the price targ...

 oppenheimer-maintains-outperform-on-zimmer-biomet-holdings-raises-price-target-to-155

Oppenheimer analyst Steven Lichtman maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Outperform and raises the price targe...

 whats-going-on-with-zimmer-biomet-shares-after-q1-earnings

Zimmer Biomet beats Q1 earnings and sales estimates, with adjusted EPS at $1.94 and quarterly sales hitting $1.889 billion, pro...

 needham-reiterates-hold-on-zimmer-biomet-holdings

Needham analyst Mike Matson reiterates Zimmer Biomet Holdings (NYSE:ZBH) with a Hold.

 zimmer-biomet-holdings-q1-2024-adj-eps-194-beats-187-estimate-sales-1889b-beat-1869b-estimate

Zimmer Biomet Holdings (NYSE:ZBH) reported quarterly earnings of $1.94 per share which beat the analyst consensus estimate of $...

 evercore-isi-group-maintains-in-line-on-zimmer-biomet-holdings-raises-price-target-to-130

Evercore ISI Group analyst Vijay Kumar maintains Zimmer Biomet Holdings (NYSE:ZBH) with a In-Line and raises the price targe...

 zimmer-biomet-reveals-partnerships-with-three-pickleball-organizations-in-us

As partners of Zimmer Biomet, the Association of Pickleball Players (APP), Professional Pickleball Association (PPA Tour), and ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION